Safety and Efficacy of a Subunit Vaccine against Flu Containing Polyoxidonium Systematic Review and Meta-Analysis of Clinical Trials

The review presents a clinical expert meta-analysis of compliance with the basic requirements for safety and efficacy Of subunit influenza vaccine containing polymer Polyoxidonium (PO) as an adjuvant (PO-AG). The results of the meta-analysis convincingly demonstrate that a reduced HA dose in combina...

Full description

Bibliographic Details
Main Author: R. Kompier
Format: Article
Language:Russian
Published: Numikom LLC 2018-09-01
Series:Эпидемиология и вакцинопрофилактика
Subjects:
Online Access:https://www.epidemvac.ru/jour/article/view/564
id doaj-7d8ee7dc8291498a94298be1b66885a4
record_format Article
spelling doaj-7d8ee7dc8291498a94298be1b66885a42021-07-28T13:31:50ZrusNumikom LLCЭпидемиология и вакцинопрофилактика2073-30462619-04942018-09-011749298458Safety and Efficacy of a Subunit Vaccine against Flu Containing Polyoxidonium Systematic Review and Meta-Analysis of Clinical TrialsR. Kompier0European consulting biotechnology company FluconsultThe review presents a clinical expert meta-analysis of compliance with the basic requirements for safety and efficacy Of subunit influenza vaccine containing polymer Polyoxidonium (PO) as an adjuvant (PO-AG). The results of the meta-analysis convincingly demonstrate that a reduced HA dose in combination with the adjuvant PO is safe and low reactogenic and induces a humoral immune response comparable to that of other inactivated vaccines without adjuvant. PO-AG is safe and effective vaccine against influenza.https://www.epidemvac.ru/jour/article/view/564influenzavaccinegrippolpolyoxidonium
collection DOAJ
language Russian
format Article
sources DOAJ
author R. Kompier
spellingShingle R. Kompier
Safety and Efficacy of a Subunit Vaccine against Flu Containing Polyoxidonium Systematic Review and Meta-Analysis of Clinical Trials
Эпидемиология и вакцинопрофилактика
influenza
vaccine
grippol
polyoxidonium
author_facet R. Kompier
author_sort R. Kompier
title Safety and Efficacy of a Subunit Vaccine against Flu Containing Polyoxidonium Systematic Review and Meta-Analysis of Clinical Trials
title_short Safety and Efficacy of a Subunit Vaccine against Flu Containing Polyoxidonium Systematic Review and Meta-Analysis of Clinical Trials
title_full Safety and Efficacy of a Subunit Vaccine against Flu Containing Polyoxidonium Systematic Review and Meta-Analysis of Clinical Trials
title_fullStr Safety and Efficacy of a Subunit Vaccine against Flu Containing Polyoxidonium Systematic Review and Meta-Analysis of Clinical Trials
title_full_unstemmed Safety and Efficacy of a Subunit Vaccine against Flu Containing Polyoxidonium Systematic Review and Meta-Analysis of Clinical Trials
title_sort safety and efficacy of a subunit vaccine against flu containing polyoxidonium systematic review and meta-analysis of clinical trials
publisher Numikom LLC
series Эпидемиология и вакцинопрофилактика
issn 2073-3046
2619-0494
publishDate 2018-09-01
description The review presents a clinical expert meta-analysis of compliance with the basic requirements for safety and efficacy Of subunit influenza vaccine containing polymer Polyoxidonium (PO) as an adjuvant (PO-AG). The results of the meta-analysis convincingly demonstrate that a reduced HA dose in combination with the adjuvant PO is safe and low reactogenic and induces a humoral immune response comparable to that of other inactivated vaccines without adjuvant. PO-AG is safe and effective vaccine against influenza.
topic influenza
vaccine
grippol
polyoxidonium
url https://www.epidemvac.ru/jour/article/view/564
work_keys_str_mv AT rkompier safetyandefficacyofasubunitvaccineagainstflucontainingpolyoxidoniumsystematicreviewandmetaanalysisofclinicaltrials
_version_ 1721273034179870720